This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Frieden, Tom. Antibiotic Resistance Threats in the United States, 2013. Atlanta (GA): Centers for Disease Control and Prevention; 2013 April 23 p 114
Hospital Adjusted Expenses per Inpatient Day [ Internet]. Henry J Kaiser Family Foundation. 2019 March 7 [cited 2019 April 3]. Available from: https://www.kff.org/health-costs/state-indicator/expenses-per-inpatient-day/
Crist-Crain M, Jaccard-Stolz D, Blingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster randomized, single-blinded intervention trial. Lancet. 2004 Feb 21;363(9409):600–7.
De Jong E, Van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomized, controlled, open-label trial. Lancet Infect Dis 2016;16(7):819–827.
Nobre V, Harbarth S, Gra JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008 Mar 1;177(5):498–505.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
AMA Research Symposium (11/9/18), NYACP Resident and Medical Student Poster Competition (2/23/19)
About this article
Cite this article
Dronamraju, V., Moffat, G.T. & Nakeshbandi, M. Adherence to Procalcitonin Measurement in Inpatient Care: a Guide for Antibiotic Stewardship and High Value Care. J GEN INTERN MED 35, 609–610 (2020). https://doi.org/10.1007/s11606-019-05197-y